Company intelligence / Profile preview
Beimei Pharmaceutical
Shenzhen, Guangdong, Chinaen.beimeiyaoye.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Beimei Pharmaceutical has over 40 pediatric-focused products (7 already commercialized), with recent approvals for proprietary respiratory products and the acquisition of TWYNEO® (acne, dermatology). Clinical trials and bioequivalence studies for oral solutions and suspensions have been completed for several pipeline products. The focus is on high-quality, innovative, and taste-masked medicines for children, with recent approvals for proprietary formulations including Procaterol Hydrochloride Oral and Inhalation Solutions.[1][3][5][7]
- Therapeutic areas
- GastroenterologyPulmonologyInfectious DiseasesNeurologyDermatology
- Modalities
- Small moleculeBiologicOral thin filmFixed-dose combination
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
03
Partnerships
LTS Lohmann Therapie-Systeme AGSol-Gel Technologies
Beyond the preview
Go deeper on Beimei Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Beimei Pharmaceutical.